Understanding how antibodies protect against SARS-CoV-2 in Latino populations
SARS-CoV-2 correlates of protection in a Latino-origin population
This study is looking at how well the immune system fights off COVID-19 in Latino communities, aiming to understand how antibodies and other immune responses can help protect people from getting seriously ill.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Puerto Rico Med Sciences NIH-funded |
| Lab location | 1 site (San Juan, United States) |
| Project ID | NIH-10688353 on NIH RePORTER |
What this research studies
This research investigates the immune response to SARS-CoV-2, particularly focusing on Latino populations who have been disproportionately affected by the virus. It aims to understand the relationship between antibody levels and their effectiveness in providing protection against COVID-19. The study will analyze immune responses, including the role of T cells, to better predict individual protection levels. By examining genetic and demographic factors, the research seeks to uncover why certain populations are more susceptible to severe outcomes from the virus.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals of Latino descent who have been affected by or are at risk for COVID-19.
Not a fit: Patients who do not identify as Latino or who have not been affected by COVID-19 may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding of COVID-19 immunity and better protective strategies for Latino populations.
How similar studies have performed: Other research has shown success in understanding immune responses to viruses, but this specific focus on Latino populations and the role of T cells is relatively novel.
Where this research is happening
San Juan, United States
- University of Puerto Rico Med Sciences — San Juan, United States (Active)
Researchers
- Principal investigator: Sariol, Carlos a — University of Puerto Rico Med Sciences
- Study coordinator: Sariol, Carlos a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.